Revascularization in severe left ventricular dysfunction: the role of viability testing.
about
Assessing myocardial perfusion after myocardial infarctionImpact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]).The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.Noninvasive assessment myocardial viability: current status and future directions.The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy aloneRadionuclide Imaging of Viable Myocardium: Is it Underutilized?Viability assessment after conventional coronary angiography using a novel cardiovascular interventional therapeutic CT system: Comparison with gross morphology in a subacute infarct swine model.Coronary-artery bypass surgery in patients with left ventricular dysfunctionNew strategies for surgical management of ischemic cardiomyopathy.Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure fromMyocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.PET and PET/CT in cardiovascular disease.Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging.Assessing the available techniques for testing myocardial viability: what does the future hold?Revascularization in heart failure in the post-STICH era.New insights from major prospective cohort studies with cardiac nuclear imaging.Current clinical applications of cardiovascular magnetic resonance imaging.The benefits of revascularization in chronic heart failure.Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.The role of myocardial viability in contemporary cardiac practice.Mid-term results of coronary bypass graft surgery in patients with ischaemic left ventricular systolic dysfunction and no detected myocardial viability.Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trialKorean Guidelines for Diagnosis and Management of Chronic Heart Failure.Correlation between delayed-enhancement magnetic resonance and nitrate myocardial Tc-99m tetrofosmin scintigraphy in myocardial infarction: a case report.Current indications for transplantation: stratification of severe heart failure and shared decision-making.Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.Prediction of long-term reverse left ventricular remodeling after revascularization or medical treatment in patients with ischemic cardiomyopathy: a comparative study between SPECT and MRI.Practical Implications of Myocardial Viability Studies.
P2860
Q27307761-3BA297CE-F1AD-45F2-9BE5-1C01C65FDB82Q33675490-7EFCF9FE-0626-4DE5-AE8A-88A4DABAFE5EQ34714829-0C3D3ECF-7E9C-451D-92D2-1FE004BF10CEQ34774619-60165605-9A28-4C0E-AC35-F16C8027EEC0Q34778284-20E3308C-4E91-4AAA-BBD4-0DE634C25350Q34892889-2CFD370F-DE59-4FCC-AEFE-361ACF054352Q36081641-E7A4BD84-38C2-42B5-B284-57095492C776Q36152222-1174E02E-08E5-4BC0-8C25-8538F2575DE8Q37134492-B4E0A4F4-4EF9-4D5F-A9AF-05D2EBD6A695Q37427428-4DA9A2EC-2D02-4F6E-B78A-5227E000BC4CQ37656286-50685CB9-9D1C-40A3-9B3A-ADB832731430Q37896144-0852BA27-D349-47F5-9394-7DDD25DC3234Q37965658-54B28220-B2CF-4817-9307-8454F884616FQ38062030-B8EDE641-E1C6-4941-A79E-71CC3330F3EDQ38154221-806C6854-8D3D-4BE0-8639-BF51F744E61EQ38197125-752B869F-C8C5-4845-8D94-3A5E1081C3F6Q38246324-327B7B03-1827-4409-9070-247544E2377FQ38286993-0EBEBC06-66A3-45AD-81E7-ABB6DFCF1E3DQ38689158-DA06835B-176E-4C93-8B51-12FD1F3DEC45Q38747232-72E4365A-2DD0-4FBD-92F0-23A51CA52B45Q38749156-77A97657-7499-4CC2-BA32-5705156942F7Q41063949-19BFE3DB-576C-46D6-97C3-003D6E94CC6CQ41686228-4BC1F994-AC3E-42F8-BC8C-DAC03682FD44Q42852531-CC6AE7E6-AA66-4726-88AC-BCDDFC0F7442Q50332202-AB50441B-3B55-477C-882B-C4480258DC88Q53267702-1F7B21F4-5C4D-4356-9702-E5DDA1FAAE80Q53277125-2CD49A04-64CA-4CEF-9F20-E2F76EAB5A73Q54983578-ED05CDFD-64CE-4058-82E4-B1CC1D4A96DF
P2860
Revascularization in severe left ventricular dysfunction: the role of viability testing.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Revascularization in severe left ventricular dysfunction: the role of viability testing.
@ast
Revascularization in severe left ventricular dysfunction: the role of viability testing.
@en
type
label
Revascularization in severe left ventricular dysfunction: the role of viability testing.
@ast
Revascularization in severe left ventricular dysfunction: the role of viability testing.
@en
prefLabel
Revascularization in severe left ventricular dysfunction: the role of viability testing.
@ast
Revascularization in severe left ventricular dysfunction: the role of viability testing.
@en
P2093
P1476
Revascularization in severe left ventricular dysfunction: the role of viability testing.
@en
P2093
Bernard J Gersh
Panithaya Chareonthaitawee
Philip A Araoz
Raymond J Gibbons
P304
P356
10.1016/J.JACC.2005.03.072
P407
P577
2005-08-01T00:00:00Z